- ASSISTANT PROFESSOR Emergency Medicine
- Dr. Makini Chisolm-Straker, MPH is an Assistant Professor of Emergency Medicine in the Department of Emergency Medicine at the Icahn School of Medicine at Mount Sinai Brooklyn. A native New Yorker, she holds a Bachelor's degree from Brown University in Religious Studies; her MD degree is also from Brown University. She completed her Emergency Medicine Residency at the Icahn School of Medicine at Mount Sinai Medical Center and Elmhurst Hospital Center. She also completed an International Emergency Medicine fellowship at Columbia University Medical Center. During her fellowship she earned a Masters in Public Health with a certificate in Public Health and Humanitarian Aid from the Mailman School of Public Health at Columbia University. She is board certified in Emergency Medicine.
Dedicated to the improvement of the health of "invisible populations," for over ten years Dr. Chisolm-Straker's work has focused on human trafficking and transgender health in emergency settings. She is the co-founder of HEAL Trafficking, Inc (www.HEALtrafficking.org), an international network of professionals combatting trafficking.
Chisolm-Straker M, Cherkas D. Altered and unstable: wet beriberi, a clinical review. The Journal of emergency medicine 2013 Sep; 45(3).
Genes N, Chisolm-Straker M. Monoarticular arthritis update: Current evidence for diagnosis and treatment in the emergency department. Emergency medicine practice 2012 May; 14(5).
Chisolm-Straker M, Richardson LD, Cossio T. Combating slavery in the 21st century: the role of emergency medicine. Journal of health care for the poor and underserved 2012 Aug; 23(3).
Shah A, Chisolm-Straker M, Alexander A, Rattu M, Dikdan S, Manini AF. Prognostic use of lactate to predict inpatient mortality in acute gastrointestinal hemorrhage. The American journal of emergency medicine 2014 Jul; 32(7).
Stark L, Rubenstein BL, Mansourian H, Spencer C, Noble E, Chisolm-Straker M. Estimating child separation in emergencies: Results from North Kivu. Child Abuse Negl. 2016 Jan 8;52:38-46. doi: 10.1016/j.chiabu.2015.12.012. [Epub ahead of print].;.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Chisolm-Straker did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Guggenheim Pavilion Floor ED
1190 Fifth Avenue
New York, NY 10029
Emergency Dept Mt Sinai Brooklyn
3201 Kings Highway
Brooklyn, NY 11234